We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Sentry Data Systems Buys Agilum Healthcare

By HospiMedica International staff writers
Posted on 09 Feb 2016
Sentry Data Systems (Deerfield Beach, FL, USA), a provider of technology solutions for healthcare organizations, has completed the acquisition of Agilum Healthcare Intelligence (Brentwood, TN, USA). More...


The acquisition is intended to add new capabilities to Sentry's current software-as-a-service (SaaS) DataNext healthcare enterprise management solutions, which provides technology and data analytics solutions that help healthcare organizations manage costs, compliance, and outcomes. The proprietary solutions provide a comprehensive financial analytics platform for pharmacy, supply chain, revenue integrity, and margin optimization to more than 76 million patients and more than 7,000 hospitals, clinics, integrated delivery networks (IDNs), and pharmacies.

Agilum Healthcare Intelligence provides enterprise business intelligence solutions that help health systems improve operating performance through increased transparency and access to actionable financial information. Merging Agilum’s capabilities will those of Sentry will provide customers with a superior range of solutions for managing costs, improving revenues, and delivering high-value care across all departments and service lines, and especially US Federal 340B management solutions for hospital pharmacies and other covered entities, as well as their contract pharmacies.

“Bringing to market the financial analytic and reporting solutions that meet our customers' business challenges remains central to our strategy,” said Travis Leonardi, CEO and Founder of Sentry. “In Agilum, we see a highly compatible organization with great potential to strengthen and augment our proprietary platform. This acquisition is the next step in delivering on Sentry's core vision to make available the data analytics and business intelligence critical for managing the entire healthcare enterprise.”

“Together with Sentry, we're going to help our customers transform their business operations to thrive in today's challenging, competitive environment, where value-based purchasing and other cost pressures put their margins at risk,” said Mark McCurry, CEO of Agilum Healthcare Intelligence. “With the pervasive financial transparency that our solutions provide, health systems will be able to implement world-class business practices to optimize their financial performance, while delivering the highest-quality care.”

The 340B Drug Discount Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices. The intent of the program is to allow covered entities to reach more eligible patients and provide more comprehensive services. Maintaining services and lowering medication costs for patients is consistent with the purpose of the program, which is named for the section authorizing it in the Public Health Service Act (PHSA). It was enacted by the US Congress as part of a larger bill signed into law by President George H.W. Bush.

Related Links:

Sentry Data Systems
Agilum Healthcare Intelligence



Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Cervical Seal
Omni Lok
New
Needle Guide Disposable Kit
Verza
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.